A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
HiFiBiO Therapeutics
Telix Pharmaceuticals (Innovations) Pty Limited
Cellestia Biotech AG
Children's National Research Institute
Stanford University
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Stanford University
National Cancer Institute (NCI)